FIELD: chemistry.
SUBSTANCE: in general formula , R is unsubstituted or substituted with -OH, C1-4alkyl or -O-C1-4alkyl, straight or branched alkyl C1-C4; R1 has formula -(L)x-R3; R3 is a fragment, chosen from a group consisting of substituted or unsubstituted phenyls, where the substitute is chosen from C1-4alkyl, -O-C1-4alkyl, -S-C1-4alkyl or fluorine; R2 has formula -(L1)y-R4; R4 is a fragment, chosen from a group consisting of i) hydrogen atom; ii) substituted with -OH, -O-C1-4alkyl or phenyl or unsubstituted straight or branched hydrocarbyls C1-C10, where the hydrocarbyl is C1-6alkyl; L and L1 are bridge fragments -NR5-; each of the fragments R5 is a hydrogen atom, straight or branched alkyl C1-C4; indices x and y can independently assume values 0 and 1.
EFFECT: compounds can be used for curing diseases, mediated by activity of phlogistic cytokines, such as arthritis.
10 cl, 4 dwg, 3 tbl, 200 ex
Title |
Year |
Author |
Number |
BICYCLIC PYRAZOLON INHIBITORS OF CYTOKINES |
2004 |
- Klark Majkl Filip
- Laflin Stiven Karl
- Golebiovski Adam
- Brugel' Todd Ehndrju
- Sabat Mark
|
RU2358976C2 |
USING SIP RECEPTOR MODULATOR |
2008 |
- Barde Iv-Alen
- Bilbe Grejm
- Deograsias Ruben
- Kun Rajner R.
- Matsumoto Tomoja
- Mir Anis Khusro
- Shubart Anna Svenja
|
RU2498796C2 |
APPLICATION OF THIAZOLIDINEDIONES FOR PREVENTION OR ONSET POSTPONEMENT OF INSULIN-INDEPENDENT DIABETES MELLITUS (NIDDM) |
1994 |
- Olefski Dzherol'D
- Antonuchi Tehmmi
- Lokvud Din
- Norris Rebekka
|
RU2195282C2 |
METHOD FOR PREPARING INTERMEDIATE COMPOUNDS |
1999 |
- Kremp S'Juzen Mehri
- Gich Nejl Dzhonatan
|
RU2224740C2 |
PYRAZOLOPYRIDINES AND ANALOGUES THEREOF |
2004 |
- Khejs Dehvid S.
- Dehnielson Majkl E.
- Gerster Dzhon F.
- Nivas Shri
- Prins Rajan B.
- Kshirsadzhar Tushar A.
- Kheppner Filip D.
- Moser Vil'Jam Kh.
- Moseman Dzhoan T.
- Radmer Mehtt'Ju R.
- Kavanagkh Morin A.
- Strong Sara A.
- Bonk Dzhejson D.
|
RU2426734C2 |
NOVEL DERIVATIVES OF AZOLIDINEDIONE, METHOD OF THEIR SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, METHOD OF PROPHYLAXIS OR TREATMENT, METHOD OF GLUCOSE LEVEL DECREASE AND INTERMEDIATE COMPOUND |
1997 |
- Lorej Vidia Bkhushan
- Lorej Bradzh Bkhushan
- Paraselli Rao Bkheema
- Gurram Ranga Madkhavan
- Ramanudzham Radzhagopalan
- Chakrabarti Randzhan
- Pakala Sarma K.S.
|
RU2200161C2 |
APPLICATION OF S1P RECEPTOR AGONIST AND METHOD OF TREATMENT, ALLEVIATION OR RETARDATION OF OPTIC NEURITIS OR DEMYELINATING DISEASES PROGRESSION |
2003 |
- Foster Karolin Ann
- Khishtand Peter S.
- Glu Pol Uill'Jam
|
RU2391094C2 |
DERIVATIVES OF N-SULFONYL-2-OXOINDOLE, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING AGENT THAT SHOWS ACTIVITY WITH RESPECT TO VASOPRESSIN AND/OR OXYTOCIN RECEPTORS |
1993 |
- Lois Fulon
- Zhorzh Gareia
- Dino Nizato
- Rishar Ru
- Klodin Serradejl'-Legal'
- Zherar Valett
- Zhan Van'On
|
RU2135469C1 |
AGENT FOR PROTECTION OF CULTURED PLANTS FROM PHYTOTOXIC ADVERSE EFFECT OF HERBICIDES, N- ACYLSULFONAMIDES |
1997 |
- Tsimer Frank
- Khaaf Klaus
- Vill'Ms Lotar
- Bauer Klaus
- Biringer Khermann
- Rozinger Kristofer
|
RU2182423C2 |
PIPERIDINE DERIVATIVES AS MODULATORS OF ACTIVITY OF CCR5 RECEPTOR, METHOD AND INTERMEDIATE COMPOUNDS FOR OBTAINING THEM, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
2002 |
|
RU2345990C2 |